Two Big Stories Shaping Korea's Near Future

This week in Korea, two pretty different but equally significant stories are making headlines — one about a global pharmaceutical giant doubling down on its commitment to Korean science, and the other about a brand-new megacity getting ready to elect its very first mayor. Let's break both of them down.

Eli Lilly Turns 150 — and Korea Is a Key Part of the Next Chapter

So here's the thing about Eli Lilly: most people outside the pharmaceutical world know it as the company behind blockbuster drugs like Mounjaro and Zepbound. But this year, the Indianapolis-based pharmaceutical giant is celebrating its 150th anniversary — and it held a special media event at its Seoul headquarters to mark the occasion.

John Bickel, the President and CEO of Eli Lilly Korea, kicked off the event with a story that goes all the way back to the American Civil War. The company's founder, Colonel Eli Lilly, served in that war and watched soldiers die from medicines that had no labeled ingredients. That experience drove him to start a pharmaceutical company in 1876 built on a radical idea for the time: quality and transparency in medicine. It's a founding story the company clearly still leans into heavily.

"Patients are not numbers — they are individuals standing before illness," Bickel said, framing the company's patient-first philosophy as something that hasn't changed in a century and a half.

What Lilly Has Built — and Where It's Headed

The numbers Bickel presented are pretty staggering. In 2025 alone, Lilly supplied medicines to 71 million patients worldwide. The company has brought more than 100 new drugs to market over its 150-year history, including 23 innovative medicines in just the last decade. And what's really interesting is how much faster things are moving now — the time from clinical development to market launch has been cut nearly in half, from 11 years down to just 6.

Right now, Lilly has a pipeline of nearly 50 drug candidates: 29 in Phase 2 clinical trials, 42 in Phase 3, and 4 under regulatory review. The company invests about 20.5 percent of its annual revenue into R&D, and more than a quarter of its global workforce is dedicated to research. Bickel put it simply: "Lilly is a science company before it is a pharmaceutical company."

On the artificial intelligence front, Lilly is partnering with NVIDIA and Insilico Medicine — a biotech firm known for AI-driven drug discovery — to accelerate its research pipeline. Internally, every employee has access to Claude (Anthropic's AI assistant) and Microsoft Copilot, tools being used across the full drug development lifecycle. On top of that, Lilly signed roughly 40 new external partnerships last year alone as part of its open innovation strategy.

Why Korea Matters to Lilly

Lilly first entered Korea in 1982. Today, the Korean subsidiary employs around 250 people and recently moved into a new headquarters building in central Seoul. But this isn't just a sales office — Lilly Korea is running 37 active clinical studies across four therapeutic areas: cardiovascular and metabolic diseases, neuroscience, immunology, and oncology.

Bickel was direct about why Korea holds a special place in Lilly's global strategy. "Korea has the three elements that matter most — world-class researchers, leading hospitals, and a strong clinical trial infrastructure," he said. That trifecta makes South Korea a highly attractive market for global pharmaceutical innovation, not just as a place to sell drugs, but as a genuine research partner.

The company also highlighted its social commitments, including a global goal called "30x30" — aiming to expand medicine access to 30 million patients in underserved regions by 2030. Lilly Korea, for its part, has been certified as a family-friendly workplace by the Korean government for 15 consecutive years.

The event even included a playful nod to Korean culture: a traditional "doljabi" ceremony — normally held for a baby's first birthday to symbolize their future path — was adapted to celebrate Lilly's 150th, with symbolic items representing the company's past and future laid out on a ceremonial table.

South Korea's Newest City Is About to Get Its First Mayor

Now, shifting gears entirely — let's talk about something that doesn't get nearly enough international attention: South Korea is about to launch a brand-new metropolitan city.

This July, the Jeonnam-Gwangju Integrated Special City will officially come into existence, merging the existing city of Gwangju and South Jeolla Province (Jeollanam-do) into a single administrative unit with a population of about 3.2 million people. The legislation enabling this merger has already passed, and on June 3rd, voters will elect the city's very first mayor. It's a genuinely historic moment for the region.

The national government has pledged 20 trillion Korean won — roughly 14 to 15 billion US dollars — in financial support for the new city. Naturally, how to spend that money has become the defining question of the mayoral race.

The Progressive Vision: A "Labor Fund for Everyone"

Kang Eun-mi, the candidate from the Justice Party — a left-leaning progressive party known for its focus on labor rights and welfare — has put inequality reduction at the heart of her platform. Her top priority, if elected, would be establishing what she calls the "Labor Fund for Everyone," a dedicated fund with an annual budget of around 200 billion won aimed at supporting workers who fall through the cracks of the existing welfare system: part-time workers, platform gig workers, and care workers.

Kang points to a real problem in the region. Gwangju reportedly has one of the highest rates of irregular employment growth in the country, while parts of South Jeolla Province face serious job crises due to downturns in petrochemical and steel industries.

"The first step of administrative integration should not be about expanding appearances, but about building a city where every citizen can live with dignity through their labor alone — where no one is left behind," Kang said.

Beyond the labor fund, her platform includes a sick pay benefit (called "sangbyeong sudang" in Korean — essentially paid sick leave for workers who currently have none), phased free public transit, and a regional youth employment guarantee program. She argues that the government's 20 trillion won pledge should go toward improving quality of life and addressing the climate crisis, rather than large-scale construction projects.

The Conservative Vision: Big Business, Big Investment

Lee Jeong-hyeon, the candidate from the People Power Party — the center-right party currently in government — is pitching a more business-forward vision. His headline promise: use about 7 trillion of the 20 trillion won to attract 10 major corporations and 100 mid-sized companies to the region, creating what he envisions as a genuine industrial hub.

Lee described the government funds not as money to be spread around, but as "seed potatoes" — an investment meant to fundamentally transform the regional economy's DNA. Target industries include data centers, energy storage systems, electric vehicles, AI, batteries, offshore wind power equipment, hydrogen, food processing, and advanced logistics.

His first-100-days priority, however, is more administrative: setting up an emergency task force to ensure the merger of two separate government systems — with all their different databases, tax records, welfare payment systems, and bus networks — goes smoothly for residents. "The most dangerous thing in the early days isn't industry, it's administrative chaos," he said, noting that disruptions to things like resident registration, tax billing, or welfare payments could quickly erode public trust in the new city.

Lee also wants to connect Jeollanam-do's renewable energy resources — the region has significant solar and wind capacity — directly to data centers and semiconductor industries that will be based in Gwangju.

The Bigger Picture

What's fascinating about this election is that it represents one of the rare moments in modern Korean governance where a genuinely new political entity is being built from scratch. The new special city will have unique legislative status, expanded autonomous powers, and a mandate to prove that regional integration can actually improve people's lives — not just redraw administrative lines on a map.

The June 3rd vote will be watched closely as a test case for how Korea manages its long-standing challenge of regional inequality and the concentration of economic opportunity in the Seoul metropolitan area. Whether the first mayor turns out to be a progressive labor advocate or a pro-business dealmaker, the stakes for 3.2 million people in the region are very real.

This article is based on reports from Insightkorea, Naver News, Naver News.